Abstract
The present invention relates to a dengue vaccine, a pharmaceutical composition comprising the same, a nucleotide sequence, and an antibody composition. The dengue vaccine of the present invention includes chimeric nonstructural protein 1, which comprises N-terminus of DV NS1 from amino-acid residues 1 to 270 and C-terminus of JEV NS1 from amino-acid residues 271 to 352 (designated DJ NS1).
| Translated title of the contribution | 登革疫苗、包含該登革疫苗之醫藥組合物、核?酸序列、以及抗體組成物 |
|---|---|
| Original language | English |
| Patent number | 2428221 |
| Publication status | Published - 1800 |
